The ODT formulation utilizes proprietary technology to improve solubility and dissolution rates, maintaining bioavailability even when taken concomitantly with acid-reducing therapies. The Food and ...
Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today announced a strategic collaboration with Microsize and Micromacinazione, pioneers in pharmaceutical ...
Cycle Pharmaceuticals (Cycle) announces the FDA approval of CAVHANZA (nilotinib) Orally Disintegrating Tablets. Launching ...
In a major regulatory update aimed at modernising and rationalising laboratory testing charges under the Drugs and Cosmetics ...
One, an integrated platform combining high-throughput ADME testing with AI-powered human pharmacokinetic projections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results